Journal
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
Volume 48, Issue 1, Pages 1-10Publisher
ASSOC RESEARCH VISION OPHTHALMOLOGY INC
DOI: 10.1167/iovs.06-0789
Keywords
-
Categories
Funding
- NATIONAL EYE INSTITUTE [R01EY007982] Funding Source: NIH RePORTER
- NEI NIH HHS [EY12335, EY07982] Funding Source: Medline
Ask authors/readers for more resources
PURPOSE. To produce a mouse model of Leber hereditary optic neuropathy. METHODS. A mutant ND4 subunit made compatible with the universal genetic code and containing an arginine-to-histidine substitution at residue 340, or a synthetic normal human ND4 gene was delivered to the mouse visual system. The expression and effects of the mutant ND4 gene on the optic nerve and cultured retinal ganglion cells was assessed by magnetic resonance imaging, immunohistochemistry, and light and transmission electron microscopy. RESULTS. The ATPc mitochondrial targeting sequence directed the allotopically expressed mutant human R340H and wildtype ND4FLAG polypeptides into mitochondria. Expression of normal human ND4 in murine mitochondria posed no ocular toxicity. In contrast, the mutant ND4 disrupted mitochondrial cytoarchitecture, elevated reactive oxygen species, induced swelling of the optic nerve head, and induced apoptosis, with a progressive demise of ganglion cells in the retina and their axons comprising the optic nerve. CONCLUSIONS. Allotopic expression of the mutant human R340H ND4 subunit of complex I replicated the hallmarks of human mitochondrial disease in the mouse. In contrast, ocular expression of the wild-type human ND4 subunit in lower mammals appears safe, suggesting that it may be useful for treatment of patients with Leber hereditary optic neuropathy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available